key: cord-0861412-pnikf0f0
authors: Miller, A. R.; Charepoo, S.; Yan, E.; Frost, R. W.; Sturgeon, Z. J.; Gibbon, G.; Balius, P. N.; Thomas, C. S.; Schmitt, M. A.; Sass, D. A.; Walters, J. B.; Flood, T. L.; Schmitt, T. A.
title: Reliability of COVID-19 data: An evaluation and reflection
date: 2021-04-27
journal: nan
DOI: 10.1101/2021.04.25.21256069
sha: fe9f0b73d1e78de8a057215fa979c1b95d03d0c7
doc_id: 861412
cord_uid: pnikf0f0

Importance: The rapid proliferation of COVID-19 has left governments scrambling, and several data aggregators are now assisting in the reporting of county cases and deaths. The different variables affecting reporting (e.g., time delays in reporting) necessitates a well-documented reliability study examining the data methods and discussion of possible causes of differences between aggregators. Objective: To statistically evaluate the reliability of COVID-19 across aggregators. Design, Setting, and Participants: Cases and deaths were collected daily by volunteers via state and local health departments, as primary sources and newspaper reports, as secondary sources. In an effort to begin comparison for reliability statistical analysis, BroadStreet collected data from other COVID-19 aggregator sources, including USAFacts, Johns Hopkins University, New York Times, The COVID Tracking Project. Main Outcomes and Measures: COVID-19 cases and death counts at the county and state levels. Results: Lower levels of inter-rater agreement were observed across aggregators associated with the number of deaths, which manifested itself in state level Bayesian estimates of COVID-19 fatality rates. Conclusions and Relevance: A national, publicly available data set is needed for current and future disease outbreaks and improved reliability in reporting.

Science, as it is, almost always wanders at a painstakingly glacial pace, and even when finished it "circles" back for self-reflection and correction, because science is never finished and never truly correct. This is the core of science, a slow, dogged and ethical pursuit of self-doubt. But then there are historical moments when science must simply just react, and when it does the ingredients are always the same: a fleeting moment of wandering brilliance, relentless perseverance, and luck. Much like the 19th century London cholera outbreak when John Snow had "his most brilliant idea:" death rates and spatially mapping 578 cholera deaths counts, the COVID-19 ( 2019 novel coronavirus) pandemic has been such a moment (1, 2) . With COVID-19 this has not been the brilliance of one or two or even three scientists, it has been the brilliance and movement of many. But when the time finally comes, as always demanded, science must circle back to evaluate and reflect. The time is now and is the current goal of this paper: to take a tiny glacial step and begin the evaluation of the COVID-19 data collection process. Our hope is that others will follow in this scientific self-critique of the COVID-19 data.

As COVID-19 slowly gained momentum in late winter and early spring of 2020, governments and other organizations scrambled to collect and present temporo-spatial data. When governments, understandably, struggled with the proliferation of COVID-19, many non-governmental organizations and universities helped with the COVID-19 data collection by innovating with data aggregation techniques (e.g., web scraping, crowd-sourcing) (1) (2) (3) (4) . Despite new technology and methods, aggregating COVID-19 data remains difficult and potentially error-ridden due to the sheer amount of data (even Snow's much smaller cholera data underestimated deaths by 8%), the novelty of the worldwide data tracking process, and the attempt to collect community-level information (e.g., county) (5) . Due to the efforts of multiple aggregators and their various methods, the COVID-19 pandemic provides a unique opportunity to evaluate the statistical reliability of near-real time and fast-moving infectious disease surveillance data. Thus, a well-documented reliability study examining data methods and possible causes of differences between aggregators is essential knowledge for future infectious disease outbreaks.

Despite the validity challenges, as H artley and Perencevich (6) have pointed out, leveraging continuous COVID-19 data from multiple sources to evaluate public health interventions in near real-time far outweighs the inevitable inaccuracies. In fact, technology has truly transformed the disease surveillance response to COVID-19 (7, 8) .

Local and federal governments, hospitals, newspaper outlets, universities, the Centers for Disease Control and Prevention (CDC) and other organizations have worked together to aggregate and survey COVID-19 (9) . Once collected and combined by aggregators, COVID-19 data has been used to create geo-maps and other data visualizations and statistical models to track, predict, and understand the disease (8, 10, 11) . This aggregated COVID-19 data has helped governments and communities formulate responses, allocate resources, measure the effectiveness of policy interventions, such as stay-at-home orders, and provide guidance in loosening restrictions (12) (13) (14) (15) .

As a result, the COVID-19 data collection and reporting process has transformed, not only our ability to surveil infectious disease, but to also forecast cases and outcomes under varying scenarios (8, 11, (16) (17) (18) . This has been integral in preventing disease and saving lives (19) . While new data and technology solutions have been invaluable in easing uncertainty and providing facts in a sea of unknowns, much of the data still remains unavailable at finer resolutions than the county-level (1, 7) . There is also the challenge of aggregating data across government agencies that collect and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint report their data differently (20) (21) (22) (23) . Information and transparency in the U.S. related to data tracking methods is often limited and varied (24) as there are numerous independently established systems for reporting disease cases and deaths (6, 9) . Thus, numerous challenges remain with collecting and aggregating valid and reliable COVID-19 data (24, 25) .

In an effort to help move "real-time" disease surveillance forward, this study attempts to make several contributions. First, we describe our COVID-19 data collection process and observations of the process, which has not previously been documented for COVID-19. Second, we examine the reliability of several COVID-19 data aggregators, including the CDC-endorsed USAFacts (USAF) (26) , Johns Hopkins University (JHU) (27) , New York Times (NYT) (28) , The COVID Tracking Project (CTP) (29) , and BroadStreet (BS), (30) at the national, state, and county levels. Lastly, it is essential to examine how COVID-19 reporting differences may be manifested in commonly used tracking statistics, thus, we examined the case fatality rate estimates at the state level.

Starting on March 16th, 2020, the Broadstreet team (consisting of approximately 120 volunteers) began tracking diagnosed cumulative cases of, and deaths due to COVID-19 reported by state and county governments. Following CDC guidelines published on 4/5/2020 (31) , volunteers tracked case and death totals using various sources and organizing them within Google Sheets. Volunteers were organized into six regional teams consisting of members acting in daily data entry, management, and quality assurance roles. Probable cases are defined by the CDC as being:

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Tests positive for presence of antigen, and either expresses COVID-19 symptoms or is epidemiologically linked to a known case; or, 3. Meeting vital records criteria (32) . All data prior to March 9th was entered from Johns Hopkins University (27) and validated through multiple methods. Between March 9th and March 16th of 2020, data was obtained retroactively from state, county, and news sources.

County-level case and death count totals were entered daily in a 24-hour cycle to track cumulative totals of the virus over time. The spreadsheet consisted of rows for each county so COVID-19 totals could be entered, as well as an "Unknown County" for cases that could not be assigned to a county. The sources used were official state or local government websites. In some cases this was supplemented with secondary sources, such as news sources, due to infrequent or nonspecific reporting by primary sources. Team managers examined the accuracy of daily totals to identify and correct errors. The Quality Assurance team then compared BroadStreet's county-level cumulative totals to those reported by other aggregators, including the NYT (28) , JHU (27) , CTP (29) , and USAF (33) , to check the validity of entered data. If significant discrepancies between aggregators existed, Quality Assurance performed research to determine the most "accurate" count totals, and then left a comment with the results of their research and any changes. All team members signed off on a tracking sheet after completing their assigned tasks to ensure accountability.

In situations where the decrease was caused by a one-day anomaly in the totals reported, this was assumed to be a reporting error and the anomalous data was updated to match the following day. In the case of a simple decrease in cumulative totals, if research did not produce an explanation of the cause, then the assumption was . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint made that this was due to cases or deaths being reassigned to a different county, and the historic totals in the initial county were reduced and transferred into an "Unknown County".

In an effort to begin comparison for reliability statistical analysis, BroadStreet collected data from other COVID-19 aggregator sources, including USAF, NYT, JHU, and CTP (27, 28, 33) . Initial examples of differences in reporting included BroadStreet reporting 89 more counties when compared to other aggregators and thousands of anomalies (number is less than previous day) in county-level case and death counts. This result is highly biased against counties with rapidly growing cases and deaths and illustrates that reported numbers are not always immediately accurate. Table 1 provides a summary of various data collection methods by the different aggregators.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint uncommonly reported US territories and/or smaller geographic delineations. In an effort to reduce the negative binomial skew resulting from a significant number of zero-count days (i.e., before COVID-19 was prevalent in a location), a modified date range of March 15, 2020 through June 30, 2020 was selected to reduce this concern while maximizing the inclusion of early count data.

A daily case and death count was calculated using a date's cumulative count minus the preceding date's cumulative count. Negative counts resulting from daily count calculation for cases and deaths were dropped from the dataset. Negative counts accounted for 0.77% of county case data, 0.21% of county death data, 0.05% of state case data, and 0.15% of state death data, respectively. Before conducting the reliability analyses, two other notable changes were made to the data; daily counts were smoothed using a 3-day moving average to account for asynchronous reporting of daily cases by each aggregator and all daily case and death counts were modified by +1 to remove any remaining zero-count data to improve Cohen Kappa coefficient estimates and reduce the number of paradoxical results.

The issue of smoothing is significant for several reasons. First, data were extremely unreliable prior to smoothing due to the reporting process and significant outliers in the data, thus the smoothed results presented here are more positive (i.e., possess higher reliability estimates) from a data aggregator perspective. Second, this finding suggests that government officials and media agencies should utilize and stress moving averages (or some other form of smoothed data) rather than raw new counts given their lack of reliability across data sources. This finding largely explains the significant increases and decreases in counts that are commonly seen in the data and reported by the media. These large changes in numbers are presumably not a function of large fluctuations in new cases or deaths, but instead an artifact of the data reporting . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint process (see Data reporting process below and S1 Figure) . This process may create unintentional panic or claim to communities.

Generally, daily COVID-19 counts are reported from a given data source (e.g., county public health websites) and then extracted by aggregators (36) . The challenge with daily reporting counts is they depend on many varying factors; for example, the time and date these numbers are reported can be nearly immediate or significantly lag.

This can be seen in Table 2 , where the numbers of new cases often differ depending on the day and time these numbers were reported. Each aggregator reports or publishes the same day counts (e.g., cases and deaths recorded on September 12th 2020), at different times and on different days (e.g., one aggregator reports September 12, 2020 counts at the end of day on September 12, 2020, whereas another aggregator may report September 12, 2020 counts on at 8 a.m. on September 13, 2020). Table 2 , both Aggregator 1 and Aggregator 3 report 67 cases on April 30, 2020, whereas Aggregator 2 reported only 19 on April 30, 2020 and the additional 48 cases the following day (May 1, 2020). While the average number of cases are comparable across data aggregators, the number of cases are rarely reliable.

Because of daily inconsistencies such as this, reliability estimates were computed and compared using the raw data and a three day moving average. Given the higher reliability of the moving average, this suggests that media and government reports, along with researchers, should consider using a moving average to better represent true trends in COVID-19 cases and deaths given the increase in reliability. This is especially important in early disease tracking when case count sample sizes are small.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint

To assess the inter-rater reliability (IRR) of COVID-19 aggregators based on new cases and death counts across the counties, states, and United States, a Kappa variant called linearly weighted Cohen's Kappa (LWCK) was used to examine agreement between paired aggregators due to the discrete nature of the data (37, 38) . LWCK inherently takes into account the influence of chance agreement, thus improving the model's sensitivity towards disagreement among rater observation pairs. Other IRR statistics were considered and examined, such as generalized linear mixed effects model intraclass correlation coefficients, intraclass correlation coefficients with mixed effects, and Spearman and Pearson correlations. Note, these statistical results often varied significantly due to large variation of data distributions and ranges, thus the LWCK statistic represents results that most closely matched the reliability quality. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. After computing LWCK statistics at the county, state, and national levels, choropleth maps were generated for at each level to help visualize COVID-19 spatial event density and understand changes in reliability across aggregators and locations.

While several standards have been proposed for IRR, this study employed the standard proposed by Cicchetti and Sparrow (39) We start with the assumption that the death counts in each state are independently sampled from beta-binomial distributions with common shape parameters α and β , and with the state-specific number of reported cases. We then estimated the global (U.S. wide) α and β parameters via maximum likelihood estimation. These shape parameters form the empirical prior for the subsequent analysis, which from this point forward is a simple Bayesian estimation of binomial proportion. With this common prior, we separately computed the posterior distribution for case fatality rate for each state, based on that state's case and death counts.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint Table 3 

USAF, NYT, and JHU yielded the highest inter-rater reliability across all states for both the number of cases and deaths when examining each pair (Fig 1) and for the average of these aggregator pairs (see Table 3 ). Average reliability for cases and deaths across all aggregators was 0.86 and 0.66, respectively. Taking a deeper look into the data, high (defined here as kappa > 0.90) mean inter-rater reliability averaged across aggregator pairings (see Table 4 ) was observed across all aggregator state case comparisons for LA, VA, SD, AZ, CT, MD, NJ, and FL when examining the number of cases. Further, the average reliability for deaths was high for only SD, ME, OK, and CT.

Note, several states (i.e., RI, OK, MI, NV, and KS) had unacceptable average reliability statistics (defined here as kappa < 0.70) associated with the number of cases, and reliability was even worse for the death rates of 29 states (see Table 4 ).

Based on these results and other results provided in Table 4 , the number of cases data were consistently more reliable than the number of deaths. Further depending on the aggregator, the variance and range in reliability within a state can be large, regardless of whether it is the number of cases or deaths. Although several examples exist, for the average number of cases and death data, CTP had a reliability of 0.76 within NY whereas BS only had a reliability of 0.23) within NY. This is important to note as it suggests that reliability is a function of both the aggregator and state.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The maps in Figures 2 and 3 provide reliability statistics at the county level for each aggregator pair based on the number of cases and deaths, respectively. These results suggest that county-level reliability appears clustered within states, such that lower county reliability tends to reside in certain states. Perhaps more interesting is that certain pairs of aggregators are more reliable in some counties than others, thus pointing to the concern that the data collection methods used may result in significantly different conclusions (both for political and research purposes) at local levels. While it is clear from Table 4 that the level of reliability is often state dependent, Figures 2 and 3 demonstrate there is also significant variation within states. Table 4 . Average Kappa (Fig 3) for Each Aggregator by State *Kappa can produce negative values 0 is random agreement among raters; 1 is complete agreement; less than 0 is generally interpreted as "no agreement." (40) (36) . Darker (1.00) to lighter (0.00) color indicates more to less agreement. For kappa, smaller sample size differences won't penalize for smaller value differences.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint

It is essential to examine case fatality rate (CFR) estimates and not just reliability statistics to explore how reliability estimates may translate into actual statistics used to track COVID-19. Since the empirical Bayes approach was repeated over time, we can see how the estimate for case fatality rate develops as more data becomes available (Fig 4) . As time passes and more cases and deaths are reported, the intervals narrow,

giving a more precise estimate for the case fatality rate. In addition, for most states, the estimates corresponding to the different aggregators begin to align with each other over time.

If we look a bit closer at the data in Figure 5 we can see how low reliability manifests itself in varying fatality estimates. For example, in NY we see reliability estimates ranging from 0.12 to 0.30 (see Table 4 ), which results in an aggregate fatality range of 0.063 to 0.082 (26.20% difference). If we go back and look at CFR estimate . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021 June 15, 2020 . This also means our confidence in estimates will be low early on, especially when sample sizes are small. Looking at AK credible intervals (CI), its smallest lower CI is 0.007 and its largest upper CI is 0.024, which are fairly large differences for potential point estimates of fatality rates. What this implies is that low reliability across aggregators can lead to significant differences in calculated disease tracking statistics, especially early in a pandemic.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021 

This study attempted to compare the reliability of COVID-19 death and cases count data across national, state, and county-levels between data aggregators. As expected, given the larger sample sizes, reliability for both cases and deaths was higher at the national level across aggregators than at state and county levels. However, death count reliability was typically lower than reliability for reported cases. Variation in reliability remained across aggregators and suggests that aggregator choice could have an impact on any data analysis or subsequent action based on the data. These differences can partially be explained by the intended purposes and collections methods of each aggregator. USAF (33) , JHU (27) , and NYT (28) have been reporting daily cases early in the pandemic and attempt to publish case and death totals in near "real-time" or as they are reported. They occasionally use county-level health departments as a source in instances where the state health department is lagging significantly behind them. Conversely, CTP (29) exclusively uses state health departments as a source to ensure their data are consistent. Broadstreet has emphasized updating data to ensure it is following a logical trend and, when possible, updating historic data to reflect more epidemiologically significant dates, such as date of death or date of symptom onset. These disparate approaches are important for different reasons (e.g., historical accuracy for retrospective analysis) and likely caused some differences in reliability between aggregators.

State level reliability (Fig 1 and Table 4 ) demonstrated notable findings as well.

First, reliability is not equal across states, suggesting that individual state practices and policies considerably influence the data reliability. Second, some reliability estimates are extremely poor suggesting analysis of these data could produce inconsistent findings.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint These results imply the need for standardization of collection and reporting methods across states, which would increase both reliability and validity of the data. USAF, JHU, NYT, CPT, and BS use various data collection and quality assurance methods, as well as sources (27) (28) (29) (30) 33) . Using state public health departments as a data source requires less maintenance and is more sustainable, but county health departments tend to be more up-to-date than state health departments, which may be of paramount importance early in a pandemic. County health departments also report data based on Council of State and Territorial Epidemiologists (CSTE) guidelines and case definitions, which can help avoid including unreasonable cases in data (41) . However, this may potentially cause datasets to include duplicate cases and cases with an unreasonable definition, making the sum of all counties overestimate the national total.

While data scraping is a quick and accurate way to enter data, it is fraught with technical challenges (e.g., updating web sites breaks the scrapping code) and in our experience is not yet feasible or quicker and more accurate than manual crowdsourcing data entry. Moreover, data scraping requires human eyes monitoring it, which may cause data to be missed in instances where the health department alters their website.

Likewise, a pipeline may fail to fetch data if the health department changes how their website is formatted; especially a potential issue if volunteers are not expecting this particular county to update daily, and may not notice a fetching issue. Updating historical data to include cases and deaths by date of symptom onset or death provides significant information when analyzing spread of virus and the effectiveness of preventative measures.

In regards to case and death data the NYT attributes cases to the location they are being treated, which may provide a more accurate picture of how the virus is spreading in particular counties and states compared to using solely the date reported.

Despite this, the information they use to assign cases to counties is inconsistently . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint provided, and the data may include out of state visitors in state totals; if these cases are also reported back to the home state, these cases will be counted twice on the national level.

While the intent of this study was not to explain aggregator differences, a short discussion of some differences are noteworthy. For example, Broadstreet often showed significant disagreement with other aggregators in several states where they update historic case and death totals to reflect date of symptom onset, date of diagnosis, or date of death.

Consequently, as a result of challenges posed in the many stages of data analyses, the reliability and validity of these statistics is critical when creating policies to protect the public and accurately modeling the disease. Disease data validity is imperative and should be the primary objective for any institute, as without validity there can be no reliability. Given that validity cannot be assessed without significant agency and/or government oversight, this study sought to evaluate COVID-19 data reliability, providing insight into the consistency of data across different sources.

Fundamentally, the validity of any statistical analysis is based on the quality of data collected (39, (41) (42) (43) (44) (45) (46) . Moreover, it is critical that aggregators are transparent in their data collection process so users can judge the validity of their process and can understand discrepancies in numbers across data collection sources. An important caveat is the validity of the final data source is largely dependent on the initial sources providing the data (e.g., state officials and hospitals). For this reason, it is critical that mechanisms are also put in place to evaluate the reliability and validity of data sources at this level. Unfortunately, to our knowledge there is currently no mechanism in place to evaluate this process or the accuracy of the data collected (2) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04. 25.21256069 doi: medRxiv preprint Due to validity concerns, several findings were clear when evaluating the reliability of reported daily cases and deaths across aggregators. First, a 3-day moving average is likely needed to ensure reliability across aggregators and eliminate large spikes or dips in the data associated with validity issues. To account for this, Cohen's Kappa was used, though with limitations, one being the potential for paradoxical coefficients such that high agreement yield zero-value coefficients, negative coefficients, or abnormally low coefficients (47, 48) . Modifying the moving average counts by +1 did improve overall kappa performance, however a handful of paradoxical results still occurred.

While it would be ideal if cases were reported using the date of infection or death rather than when the event was reported and all aggregators used these dates, this was not the case and frequently resulted in significant spikes on certain days (e.g., cases often dropped over the weekend and spiked on Monday or Tuesday, with the level of these spikes often being agency or county dependent). While the aforementioned example associated with data spikes certainly impacts the data's validity, one should be cognizant that it should not impact the reliability (i.e., aggregators should reliability report those spikes). With that said, it is clear from our evaluation of the aggregator's data that the practices applied across aggregators is not consistent (Table 3) , thus practices should be put in place to increase reliability rather than relying on data smoothing methods to reduce the impact of inconsistent reporting.

The general conclusion from this study is that the United States needs a national public data reporting system that is free from the inconsistencies and data discrepancies that result from decentralized data collection and aggregation. The technology to make this happen currently exists. More than 95% of U.S. hospitals use an Electronic Health Record system (5) , which can be integrated into a near-real-time . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Another likely contributor is differences in reporting. The lack of a nation-wide standard for reporting deaths means that different states may be more or less stringent in attributing deaths to the virus. A third possible source for disagreement across states is discrimination in testing. Due to limited availability of testing, some states became more restrictive in providing free tests to the public. Tests in such states were prioritized towards those exhibiting more severe symptoms, and consequently could have introduced case sampling bias towards a higher-risk subset of the greater population of infected individuals. Through future research, different databases and public sources will be incredibly valuable in the tracking and documentation of cases and deaths (49, 50) .

Standardizing infectious disease data collection and dissemination would empower practitioners to do more linking to other variables and analysis. For example, the Area Deprivation Index is a powerful indicator of many health outcomes (50) (51) (52) . The Centers for Disease Control and Prevention (CDC) reports social inequality and health . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint systems issues as a cause for an increased risk of health and socioeconomic impacts as a result of COVID-19 for these groups (53, 54) . Data reporting for race began in early April, with Louisiana being the first to report data (54) (55) (56) . Immediately, disparities in mortality deaths were noticed, and a June 2020 report by the CDC confirmed this disparity was widespread. Ultimately, we need to nationally mandate explicit methods for reportable infectious diseases that allows for comparing data across geographic levels. This is a political problem that can only be solved with increased public health funding at all levels of government to fully modernize disease reporting in the US.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

The first step in Washington state's COVID-19 protocol involves identifying the symptomatic individua l (S1 Figure) . This individual will either be expressing symptoms of COVID-19, is a close contact of a case of COVID-19, is at-risk of transmitting COVID-19 due to various factors (below), or is a member of a group atypically prone to adverse COVID-19 outcomes undergoes testing through a healthcare provider or at a testing site. The provider/testing site collects information during the testing process, including contact information, demographic, race and ethnicity (57) .

After identification, most tests are sent to clinical labs, and in certain situations, the specimen is sent to the Public Health Lab (which tends to have shorter wait times before returning a result). This is determined by various factors, most of which are used to identify people who work/live in environments where they are more likely to transmit the virus (58, 59) . Next, regardless of which lab conducted testing, all results (positive, negative, and inconclusive) are shared with the local health jurisdiction (county health department). If the suspicion that an individual is carrying COVID-19 is high, a negative test will be repeated. Local health jurisdictions must be notified immediately of a positive result by telephone, regardless of the hour. Isolate or clinical specimens from a positive test must be sent to the Public Health Lab within two business days of the test result, if tested at a clinical lab (43,44,57,60) .

After results are received, local health jurisdictions input case information into the Washington Disease Reporting System (WDRS) to report them to the Washington State Department of Health. The CDC is also notified through the WDRS. Data reported to the CDC is de-identified, and reported through HL7 messaging or a correctly formatted .CSV file. Case interviews/contact tracing are used to fill in any information not gathered . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint during the initial test. Local health jurisdictions may not be given complete contact information for individuals, delaying notification (45,46,61,62) .

Individuals are then notified of positive results in various ways, depending on where they had their test done. They may receive a call from the healthcare provider, from local health jurisdictions, or from their tester. Individuals are instructed to go into isolation. Contact tracers conduct interviews to determine how the virus was contracted, where possible. Contact tracers identify close contacts, who are notified, instructed to quarantine, and monitored for two weeks for symptoms of COVID-19. Monitoring of close contacts ceases after two weeks. Isolation for COVID patients ceases after their symptoms improve, they have had at least ten days pass since initial appearance of symptoms, and have gone three days without a fever. If never symptomatic, isolation ends ten days after a positive test (45, 59, 63, 64) . This process will have slight variations depending on the laws in a given state.

The CDC allows for several methods of reporting this data (61) . It is important to note that there may be numerous caveats of how COVID-19 data is reported and aggregated and ultimately making its way to the CDC. For example, on July 10, 2020

The U.S. Department of Health and Human Services (HHS) directed hospitals that perform COVID-19 testing or that use certain commercial labs to report using the HHS Protect System. Thus, some testing data bypassed the CDC and went directly to the HHS (65) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint S1 Figure. Visualization of Washington state's COVID-19 protocol.

Note: Time period of this chart is July 10, 2020. Process may have been updated.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.25.21256069 doi: medRxiv preprint

Applications of digital technology in COVID-19 pandemic planning and response. Lancet Digit Health

COVID-19 Is a Data Science Issue. Patterns N Y N

Data Collection and Reporting | NNDSS

A County-level Dataset for Informing the United States' Response to COVID-19. ArXiv200400756 Phys Q-Bio

The mortality rates and the space-time patterns of John Snow's cholera epidemic map

Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis

Digital technologies in the public-health response to COVID-19

Real-time estimation of disease activity in emerging outbreaks using internet search information

Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics

Modeling the dynamics of the COVID-19 population in Australia: A probabilistic analysis

Thinking Globally, Acting Locally -The U.S. Response to Covid-19

CDC activities and initiatives supporting the COVID-19 response and the President's plan for opening America up again

Digital tools against COVID-19: taxonomy, ethical challenges, and navigation aid

COVID-19 Government Response Event Dataset (CoronaNet v.1.0). Nat Hum Behav

Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study

Estimating the severity of COVID-19: Evidence from the Italian epicenter

Use of social media big data as a novel HIV surveillance tool in South Africa

COVID-19) in the U.S. Centers for Disease Control and Prevention

Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months

Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing

The Role of Expert Judgment in Statistical Inference and Evidence-Based Decision-Making

Bridging Clinical Investigators and Statisticians: Writing the Statistical Methodology for a Research Proposal

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States

US Coronavirus Cases & Deaths by State

COVID-19 United States Cases by County

Johns Hopkins Coronavirus Resource Center

Latest Map and Case Count -The New York Times

The COVID Tracking Project

The COVID Tracking Project

BroadStreet Covid19 Data Project

Centers for Disease Control and Prevention

Centers for Disease Control and Prevention

Detailed Methodology and Sources: COVID-19 Data

To Bring Data Transparency in the Era of COVID-19. ArXiv200510948 Cs Q-Bio

R: A Language and Environment for Statisctical Computing

Computing Inter-Rater Reliability for Observational Data: An Overview and Tutorial

A note on the linearly weighted kappa coefficient for ordinal scales

Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior

Interrater reliability: the kappa statistic

Council of State and Territorial Epidemiologists

The Importance of Proper Death Certification During the COVID-19 Pandemic

covid-19labreporting State of Washington

Washington Disease Reporting System General Communicable Diseases Instruction Manual

High agreement but low Kappa: I. the problems of two paradoxes

High agreement but low kappa: II. Resolving the paradoxes -Journal of Clinical Epidemiology

Publicly available COVID-19 data for analytics

Area Deprivation Index (ADI) -Marketplace -Google Cloud Platform

Area Deprivation Index and Vulnerable Populations -How do I find them?

Increased Risk Factors for Exposure

CDC. Health Equity Considerations & Racial & Ethnic Minority Groups [Internet

Centers for Disease Control and Prevention

Centers for Disease Control and Prevention

Interim COVID-19 Testing Guidance for Healthcare Providers. Wash State Dep Health

What is contact tracing?

Letter to Lab Directors/Managers [Internet]. State of Washington Department of Health

COVID-19 testing locations in King County -King County

COVID-19 | Testing

White House to hospitals: Bypass CDC, report COVID-19 data directly to HHS | Healthcare IT News